Nutra Pharma has announced that it will be presenting and exhibiting at the upcoming Accredited Members, Inc. Winter 2010 Small Cap/Micro Cap Investment Conference in Scottsdale, Arizona, and at The World MoneyShow in Orlando, Florida.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it will be presenting and exhibiting at the upcoming Accredited Members, Inc. Winter 2010 Small Cap/Micro Cap Investment Conference in Scottsdale, Arizona, and at The World MoneyShow in Orlando, Florida.
“This is an exciting time for Nutra Pharma as we continue to rollout our first drug products and begin generating our first significant revenues in the history of the Company,” explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. “These conferences provide excellent opportunities to expand our presence within the investment community and share our unique and exciting growth story,” he concluded.
The Accredited Members, Inc. Winter 2010 Small Cap/Micro Cap Investment Conference, which is scheduled for February 1st to February 3rd 2010, will be hosted at the Four Seasons Resort in Scottsdale Arizona. The World MoneyShow is scheduled for February 3rd to February 6th 2010 and will be held at the Gaylord Palms Hotel and Convention Center in Orlando, Florida.
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The Company's business is subject to various risks, which are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"). Exhibiting at the upcoming shows in Scottsdale, Arizona, and Orlando, Florida, should not be construed as an indication in any way whatsoever of the value of the Company or its common stock. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.